Label Changes for:
Diovan (Valsartan) Tablets
Changes have been made to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June and December 2011, February and August 2012
- Do not use in patients with known hypersensitivity to any component